SBI Healthcare Opportunities Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1896 Cr | ₹3933 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 31 Dec 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.14 | 1.94 |
| Manager | Dhruv Muchhal | Pradeep Kesavan |
| ISIN Code | INF179KC1HL7 | INF200K01446 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | 1.84% | 1.26% |
| 6 Month | 8.77% | 3.02% |
| 1 Year | 4.7% | 1.03% |
| 3 Year | - | 23.72% |
| 5 Year | - | 19.49% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | 3.69% | 2.18% |
| 1 Year | 13.9% | 7.47% |
| 3 Year | - | 22.23% |
| 5 Year | - | 20.18% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 27.59% | 15.65% |
| 3 Year | - | 17.81% |
| 5 Year | - | 12.99% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | - | 14.07% |
| Sharp | - | 1.18% |
| Beta | - | 0.84% |
| Alpha | - | 3.29% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Dhruv Muchhal | Pradeep Kesavan |
| Total AUM | ₹520687 Cr | ₹434274 Cr |
| Funds Managed | 40 | 43 |
| HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 7.7 | 13.04 |
| Mid Cap | 30.89 | 27.23 |
| Small Cap | 35.06 | 34.17 |
| Large Cap | 26.35 | 25.56 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.03 | 3.64 |
| Basic Materials | 2.31 | 5.69 |
| Healthcare | 96.66 | 90.67 |
Top Comparisons
Bandhan Ultra Short Duration Fund - Regular Plan - Growth
3Y Returns7.19%
Axis Ultra Short Duration Fund - Regular Plan Growth
3Y Returns6.77%
ITI Ultra Short Duration Fund Regular - Growth
3Y Returns6.39%
HSBC Ultra Short Duration Fund - Regular Growth
3Y Returns7.17%
ITI Balanced Advantage Fund Regular - Growth
3Y Returns11.35%
Franklin India Balanced Advantage Fund- Growth
3Y Returns12.83%
Aditya Birla Sun Life Flexi Cap Fund - Growth - Regular Plan
3Y Returns16.98%
LIC MF Flexi Cap Fund-Growth
3Y Returns15.3%